Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma.

In a univariate cause-specific Cox regression analysis, with the non-CTX group as reference, intensive CTX bridging showed a nearly significant association with the time to severe infection (HR, 2.32; 95% CI, 0.99-5.43; P = .05), whereas no association was observed for the intermediate CTX group (HR, 0.98; 95% CI, 0.45-2.11; P = .95).

also in 3,349 other papers